Actively Recruiting

Phase Not Applicable
All Genders
Healthy Volunteers
NCT06725901

Pediatric Neurogenetic Diagnosis Support Platform

Led by Universidad Nacional Andres Bello · Updated on 2025-05-29

9

Participants Needed

1

Research Sites

55 weeks

Total Duration

On this page

Sponsors

U

Universidad Nacional Andres Bello

Lead Sponsor

H

Hospital Carlos Van Buren

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study evaluates a diagnostic support platform, DIAGEN-IA, designed to identify pediatric neurological diseases with a genetic basis. Conducted at Carlos Van Buren Hospital in Chile, it aims to determine if the platform reduces inappropriate referrals to clinical geneticists, improves diagnostic evaluations, enhances referral quality, and increases user satisfaction. A prospective before-and-after design will compare outcomes across two phases: baseline data collection and an intervention phase using DIAGEN-IA. Healthcare professionals will use the platform to guide referrals and diagnostic studies. Outcomes include referral appropriateness, completeness of evaluations, quality of referrals, and user satisfaction.

CONDITIONS

Official Title

Pediatric Neurogenetic Diagnosis Support Platform

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Neuropediatricians working in the Carlos Van Buren Hospital.
  • Providing care to pediatric patients (under 18 years of age).
  • Native Spanish speakers or those with certified C1-level Spanish proficiency.
  • Responsible for referring pediatric patients with suspected rare diseases to a clinical geneticist.
Not Eligible

You will not qualify if you...

  • Refusal to participate.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital Carlos Van Buren

Valparaíso, Valparaiso, Chile, 2341131

Actively Recruiting

Loading map...

Research Team

N

Nicole Nakousi-Capurro, MD

CONTACT

C

Carla Taramasco, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here